238 related articles for article (PubMed ID: 10388343)
41. ESI-MS/MS study of acylcarnitine profiles in urine from patients with organic acidemias and fatty acid oxidation disorders.
Kobayashi H; Hasegawa Y; Endo M; Purevsuren J; Yamaguchi S
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Aug; 855(1):80-7. PubMed ID: 17301002
[TBL] [Abstract][Full Text] [Related]
42. Sudden infant death syndrome and inherited disorders of fatty acid beta-oxidation.
Harpey JP; Charpentier C; Paturneau-Jouas M
Biol Neonate; 1990; 58 Suppl 1():70-80. PubMed ID: 2265221
[TBL] [Abstract][Full Text] [Related]
43. Postmortem screening for fatty acid oxidation disorders by analysis of Guthrie cards with tandem mass spectrometry in sudden unexpected death in infancy.
Wilcox RL; Nelson CC; Stenzel P; Steiner RD
J Pediatr; 2002 Dec; 141(6):833-6. PubMed ID: 12461502
[TBL] [Abstract][Full Text] [Related]
44. Recognition of medium-chain acyl-CoA dehydrogenase deficiency in asymptomatic siblings of children dying of sudden infant death or Reye-like syndromes.
Roe CR; Millington DS; Maltby DA; Kinnebrew P
J Pediatr; 1986 Jan; 108(1):13-8. PubMed ID: 3944676
[TBL] [Abstract][Full Text] [Related]
45. Metabolic disease and sudden, unexpected death in infancy.
Bennett MJ; Powell S
Hum Pathol; 1994 Aug; 25(8):742-6. PubMed ID: 8056419
[TBL] [Abstract][Full Text] [Related]
46. [The phenylpropionate loading test and medium-chain acyl CoA dehydrogenase deficiency].
De Parscau L; Barrois S; Vianey-Liaud C; Divry P; Guibaud P
Arch Fr Pediatr; 1989 Apr; 46(4):285-6. PubMed ID: 2751399
[No Abstract] [Full Text] [Related]
47. Acylcarnitines in the urine of a patient with medium chain acyl-CoA dehydrogenase (MCAD) deficiency and in normal children.
Schmidt-Sommerfeld E; Penn D; Kerner J; Bieber LL
Prog Clin Biol Res; 1990; 321():403-9. PubMed ID: 2326301
[No Abstract] [Full Text] [Related]
48. [Do defects in fatty acid oxidation cause sudden infant death?].
Hagenfeldt L; von Döbeln V
Lakartidningen; 1989 Apr; 86(17):1575-6. PubMed ID: 2725141
[No Abstract] [Full Text] [Related]
49. Production and disposal of medium-chain fatty acids in children with medium-chain acyl-CoA dehydrogenase deficiency.
Heales SJ; Thompson GN; Massoud AF; Rahman S; Halliday D; Leonard JV
J Inherit Metab Dis; 1994; 17(1):74-80. PubMed ID: 8051939
[TBL] [Abstract][Full Text] [Related]
50. Electrospray tandem mass spectrometry for analysis of acylcarnitines in dried postmortem blood specimens collected at autopsy from infants with unexplained cause of death.
Chace DH; DiPerna JC; Mitchell BL; Sgroi B; Hofman LF; Naylor EW
Clin Chem; 2001; 47(7):1166-82. PubMed ID: 11427446
[TBL] [Abstract][Full Text] [Related]
51. Frequency of 985A-to-G mutation in medium-chain acyl-CoA dehydrogenase gene among patients with sudden infant death syndrome, Reye syndrome, severe motor and intellectual disabilities and healthy newborns in Japan.
Nagao M
Acta Paediatr Jpn; 1996 Aug; 38(4):304-7. PubMed ID: 8840534
[TBL] [Abstract][Full Text] [Related]
52. Bile acylcarnitine profiles in pediatric liver disease do not interfere with the diagnosis of long-chain fatty acid oxidation defects.
Fuda F; Narayan SB; Squires RH; Bennett MJ
Clin Chim Acta; 2006 May; 367(1-2):185-8. PubMed ID: 16414039
[TBL] [Abstract][Full Text] [Related]
53. A murine model for short-chain acyl-CoA dehydrogenase deficiency.
Wood PA; Amendt BA; Rhead WJ; Armstrong D; Millington DS; Inoue F
Prog Clin Biol Res; 1990; 321():427-34. PubMed ID: 2326304
[No Abstract] [Full Text] [Related]
54. Medium-chain acyl-CoA dehydrogenase deficiency: postmortem diagnosis in a case of sudden infant death and neonatal diagnosis of an affected sibling.
Bennett MJ; Rinaldo P; Millington DS; Tanaka K; Yokota I; Coates PM
Pediatr Pathol; 1991; 11(6):889-95. PubMed ID: 1775402
[TBL] [Abstract][Full Text] [Related]
55. Investigation of beta-oxidation intermediates in normal and MCAD-deficient human fibroblasts using tandem mass spectrometry.
Nada MA; Chace DH; Sprecher H; Roe CR
Biochem Mol Med; 1995 Feb; 54(1):59-66. PubMed ID: 7551818
[TBL] [Abstract][Full Text] [Related]
56. Biochemical diagnosis of fatty acid oxidation disorders by metabolite analysis of postmortem liver.
Boles RG; Martin SK; Blitzer MG; Rinaldo P
Hum Pathol; 1994 Aug; 25(8):735-41. PubMed ID: 8056418
[TBL] [Abstract][Full Text] [Related]
57. Medium chain acyl CoA dehydrogenase deficiency.
Lancet; 1991 Aug; 338(8766):544-5. PubMed ID: 1678805
[No Abstract] [Full Text] [Related]
58. Investigation of inborn errors of metabolism in unexpected infant deaths.
Emery JL; Howat AJ; Variend S; Vawter GF
Lancet; 1988 Jul; 2(8601):29-31. PubMed ID: 2898629
[No Abstract] [Full Text] [Related]
59. Fatty acid beta-oxidation in leukocytes from control subjects and medium-chain acyl-CoA dehydrogenase deficient patients.
Wanders RJ; Ijlst L
Biochim Biophys Acta; 1992 Jan; 1138(1):80-4. PubMed ID: 1737072
[TBL] [Abstract][Full Text] [Related]
60. Inborn Errors of Metabolism with Myopathy: Defects of Fatty Acid Oxidation and the Carnitine Shuttle System.
El-Gharbawy A; Vockley J
Pediatr Clin North Am; 2018 Apr; 65(2):317-335. PubMed ID: 29502916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
